Evidence map›Paper›PMID 32180561›Full record

ArticleMolecular metabolism2020

PGC-1α isoforms coordinate to balance hepatic metabolism and apoptosis in inflammatory environments.

Mélissa Léveillé, Aurèle Besse-Patin, Nathalie Jouvet, Aysim Gunes, Sarah Sczelecki, Stewart Jeromson, Naveen P Khan, Cindy Baldwin, Annie Dumouchel, Jorge C Correia and 4 more

Open access · goldAbstract read
In one paragraph

Article in Molecular metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Cells · 2021
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Mélissa LéveilléInstitut de recherches cliniques de Montreal (IRCM), Montreal, Quebec, Canada; Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada.
Aurèle Besse-PatinInstitut de recherches cliniques de Montreal (IRCM), Montreal, Quebec, Canada; Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada.
Nathalie JouvetInstitut de recherches cliniques de Montreal (IRCM), Montreal, Quebec, Canada; Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada.
Aysim GunesInstitut de recherches cliniques de Montreal (IRCM), Montreal, Quebec, Canada; Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada.
Sarah SczeleckiInstitut de recherches cliniques de Montreal (IRCM), Montreal, Quebec, Canada; Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada.
Stewart JeromsonInstitut de recherches cliniques de Montreal (IRCM), Montreal, Quebec, Canada.
Naveen P KhanInstitut de recherches cliniques de Montreal (IRCM), Montreal, Quebec, Canada; Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada.
Cindy BaldwinInstitut de recherches cliniques de Montreal (IRCM), Montreal, Quebec, Canada.
Annie DumouchelInstitut de recherches cliniques de Montreal (IRCM), Montreal, Quebec, Canada.
Jorge C CorreiaDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Paulo R JannigDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Jonathan BoulaisInstitut de recherches cliniques de Montreal (IRCM), Montreal, Quebec, Canada.
Jorge L RuasDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Jennifer L EstallInstitut de recherches cliniques de Montreal (IRCM), Montreal, Quebec, Canada; Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada; Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada. Electronic address: jennifer.estall@ircm.qc.ca.
Montreal Clinical Research Institute · CAKarolinska Institutet · SE

Funding

CIHR PJT-148771
6 · The paper itself

Abstract

objectiveThe liver is regularly exposed to changing metabolic and inflammatory environments. It must sense and adapt to metabolic need while balancing resources required to protect itself from insult. Peroxisome proliferator activated receptor gamma coactivator-1 alpha (PGC-1α) is a transcriptional coactivator expressed as multiple, alternatively spliced variants transcribed from different promoters that coordinate metabolic adaptation and protect against inflammation. It is not known how PGC-1α integrates extracellular signals to balance metabolic and anti-inflammatory outcomes.

methodsPrimary mouse hepatocytes were used to evaluate the role(s) of different PGC-1α proteins in regulating hepatic metabolism and inflammatory signaling downstream of tumor necrosis factor alpha (TNFα). Gene expression and signaling analysis were combined with biochemical measurement of apoptosis using gain- and loss-of-function in vitro and in vivo.

resultsHepatocytes expressed multiple isoforms of PGC-1α, including PGC-1α4, which microarray analysis showed had common and isoform-specific functions linked to metabolism and inflammation compared with canonical PGC-1α1. Whereas PGC-1α1 primarily impacted gene programs of nutrient metabolism and mitochondrial biology, TNFα signaling showed several pathways related to innate immunity and cell death downstream of PGC-1α4. Gain- and loss-of-function models illustrated that PGC-1α4 uniquely enhanced expression of anti-apoptotic gene programs and attenuated hepatocyte apoptosis in response to TNFα or lipopolysaccharide (LPS). This was in contrast to PGC-1α1, which decreased the expression of a wide inflammatory gene network but did not prevent hepatocyte death in response to cytokines.

conclusionsPGC-1α variants have distinct, yet complementary roles in hepatic responses to metabolism and inflammation, and we identify PGC-1α4 as an important mitigator of apoptosis.

Indexed as

ApoptosisAnimalsCell LineFemaleHepatocytesInflammationMaleMiceMice, Inbred C57BLMice, KnockoutPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaProtein IsoformsPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPpargc1a protein, mouseProtein IsoformsApoptosisInflammationLiverMetabolismPGC-1 isoforms

Identifiers

PMID32180561
PMCPMC7011010
OpenAlexW2999473969

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.